Related references
Note: Only part of the references are listed.D-Alanine: D-alanine ligase as a new target for the flavonoids quercetin and apigenin
Dalei Wu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Data completeness -: the Achilles heel of drug-target networks
Jordi Mestres et al.
NATURE BIOTECHNOLOGY (2008)
Small-molecule aggregates inhibit amyloid polymerization
Brian Y. Feng et al.
NATURE CHEMICAL BIOLOGY (2008)
Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1
Ki Won Lee et al.
CARCINOGENESIS (2007)
Modeling promiscuity based on in vitro safety pharmacology profiling data
Kamal Azzaoui et al.
CHEMMEDCHEM (2007)
Inhibition of mammalian thioredoxin reductase by some flavonoids: Implications for myricetin and quercetin anticancer activity
J Lu et al.
CANCER RESEARCH (2006)
In vitro safety pharmacology profiling:: an essential tool for successful drug development
S Whitebread et al.
DRUG DISCOVERY TODAY (2005)
Inhibition of human cytochromes P450 by components of Ginkgo biloba
LL von Moltke et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Pursuing the leadlikeness concept in pharmaceutical research
MM Hann et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Identification and prediction of promiscuous aggregating inhibitors among known drugs
J Seidler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Effect of detergent on promiscuous inhibitors
AJ Ryan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
